Bioequivalence of RU-31 Tablet Dosage Form
The bioequivalence of the tablet dosage form of RU-31 substance was studied. The main pharmacokinetic parameters were determined. The actual relative bioequivalence index was calculated and turned out to be ~100%. RU-31 from tablets did not accumulate upon triple administration at a dose of 10 mg/kg...
Gespeichert in:
| Veröffentlicht in: | Pharmaceutical chemistry journal 2021-07, Vol.55 (4), p.328-330 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 330 |
|---|---|
| container_issue | 4 |
| container_start_page | 328 |
| container_title | Pharmaceutical chemistry journal |
| container_volume | 55 |
| creator | Spasov, A. A. Smirnova, L. A. Ryabukha, A. F. Kuznetsov, K. A. Velikopol’skaya, M. V. Yakovlev, D. S. |
| description | The bioequivalence of the tablet dosage form of RU-31 substance was studied. The main pharmacokinetic parameters were determined. The actual relative bioequivalence index was calculated and turned out to be ~100%. RU-31 from tablets did not accumulate upon triple administration at a dose of 10 mg/kg. |
| doi_str_mv | 10.1007/s11094-021-02421-0 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A671192607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A671192607</galeid><sourcerecordid>A671192607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-8c0db53293471159fbef489b5cc9bee811f7ce96cec9cdb3d91641070ad7a25d3</originalsourceid><addsrcrecordid>eNp9kFFLAzEMx4soOKdfwKd7Fm4m7d31-jinU2EgyAa-lV4vHTe2q7ab4Ldf5_ksIQmE_P4kf8ZuESYIIO8jIqgiB44pi1M9YyMspcgVCDxnIwCFOZbwccmuYtwAJEzwEbt76Dx9Hbpvs6XeUuZd9r7KBWZL02xpnz36aNaUzX3YXbMLZ7aRbv76mK3mT8vZS754e36dTRe55TXu89pC25SCK1FIxFK5hlxRq6a0VjVENaKTllRlySrbNqJVWBUIEkwrDS9bMWaTQXedbtJd7_w-GJuipV1nfU-uS_NpldQVr0AmgA-ADT7GQE5_hm5nwo9G0Cd79GCPTvboX3s0JEgMUEzL_ZqC3vhD6NNj_1FHtLZl8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bioequivalence of RU-31 Tablet Dosage Form</title><source>Springer Nature - Complete Springer Journals</source><creator>Spasov, A. A. ; Smirnova, L. A. ; Ryabukha, A. F. ; Kuznetsov, K. A. ; Velikopol’skaya, M. V. ; Yakovlev, D. S.</creator><creatorcontrib>Spasov, A. A. ; Smirnova, L. A. ; Ryabukha, A. F. ; Kuznetsov, K. A. ; Velikopol’skaya, M. V. ; Yakovlev, D. S.</creatorcontrib><description>The bioequivalence of the tablet dosage form of RU-31 substance was studied. The main pharmacokinetic parameters were determined. The actual relative bioequivalence index was calculated and turned out to be ~100%. RU-31 from tablets did not accumulate upon triple administration at a dose of 10 mg/kg.</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-021-02421-0</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Medicine ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy</subject><ispartof>Pharmaceutical chemistry journal, 2021-07, Vol.55 (4), p.328-330</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>COPYRIGHT 2021 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11094-021-02421-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11094-021-02421-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids></links><search><creatorcontrib>Spasov, A. A.</creatorcontrib><creatorcontrib>Smirnova, L. A.</creatorcontrib><creatorcontrib>Ryabukha, A. F.</creatorcontrib><creatorcontrib>Kuznetsov, K. A.</creatorcontrib><creatorcontrib>Velikopol’skaya, M. V.</creatorcontrib><creatorcontrib>Yakovlev, D. S.</creatorcontrib><title>Bioequivalence of RU-31 Tablet Dosage Form</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>The bioequivalence of the tablet dosage form of RU-31 substance was studied. The main pharmacokinetic parameters were determined. The actual relative bioequivalence index was calculated and turned out to be ~100%. RU-31 from tablets did not accumulate upon triple administration at a dose of 10 mg/kg.</description><subject>Medicine</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kFFLAzEMx4soOKdfwKd7Fm4m7d31-jinU2EgyAa-lV4vHTe2q7ab4Ldf5_ksIQmE_P4kf8ZuESYIIO8jIqgiB44pi1M9YyMspcgVCDxnIwCFOZbwccmuYtwAJEzwEbt76Dx9Hbpvs6XeUuZd9r7KBWZL02xpnz36aNaUzX3YXbMLZ7aRbv76mK3mT8vZS754e36dTRe55TXu89pC25SCK1FIxFK5hlxRq6a0VjVENaKTllRlySrbNqJVWBUIEkwrDS9bMWaTQXedbtJd7_w-GJuipV1nfU-uS_NpldQVr0AmgA-ADT7GQE5_hm5nwo9G0Cd79GCPTvboX3s0JEgMUEzL_ZqC3vhD6NNj_1FHtLZl8w</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Spasov, A. A.</creator><creator>Smirnova, L. A.</creator><creator>Ryabukha, A. F.</creator><creator>Kuznetsov, K. A.</creator><creator>Velikopol’skaya, M. V.</creator><creator>Yakovlev, D. S.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210701</creationdate><title>Bioequivalence of RU-31 Tablet Dosage Form</title><author>Spasov, A. A. ; Smirnova, L. A. ; Ryabukha, A. F. ; Kuznetsov, K. A. ; Velikopol’skaya, M. V. ; Yakovlev, D. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-8c0db53293471159fbef489b5cc9bee811f7ce96cec9cdb3d91641070ad7a25d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Medicine</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spasov, A. A.</creatorcontrib><creatorcontrib>Smirnova, L. A.</creatorcontrib><creatorcontrib>Ryabukha, A. F.</creatorcontrib><creatorcontrib>Kuznetsov, K. A.</creatorcontrib><creatorcontrib>Velikopol’skaya, M. V.</creatorcontrib><creatorcontrib>Yakovlev, D. S.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spasov, A. A.</au><au>Smirnova, L. A.</au><au>Ryabukha, A. F.</au><au>Kuznetsov, K. A.</au><au>Velikopol’skaya, M. V.</au><au>Yakovlev, D. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioequivalence of RU-31 Tablet Dosage Form</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2021-07-01</date><risdate>2021</risdate><volume>55</volume><issue>4</issue><spage>328</spage><epage>330</epage><pages>328-330</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>The bioequivalence of the tablet dosage form of RU-31 substance was studied. The main pharmacokinetic parameters were determined. The actual relative bioequivalence index was calculated and turned out to be ~100%. RU-31 from tablets did not accumulate upon triple administration at a dose of 10 mg/kg.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s11094-021-02421-0</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-150X |
| ispartof | Pharmaceutical chemistry journal, 2021-07, Vol.55 (4), p.328-330 |
| issn | 0091-150X 1573-9031 |
| language | eng |
| recordid | cdi_gale_infotracacademiconefile_A671192607 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Medicine Organic Chemistry Pharmacology/Toxicology Pharmacy |
| title | Bioequivalence of RU-31 Tablet Dosage Form |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A01%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioequivalence%20of%20RU-31%20Tablet%20Dosage%20Form&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Spasov,%20A.%20A.&rft.date=2021-07-01&rft.volume=55&rft.issue=4&rft.spage=328&rft.epage=330&rft.pages=328-330&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-021-02421-0&rft_dat=%3Cgale_cross%3EA671192607%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A671192607&rfr_iscdi=true |